Logo
Cogent Biosciences

Director, Field Operations

Cogent Biosciences, Waltham, Massachusetts, United States, 02254

Save Job

Overview Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V drives systemic mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a cancer with strong dependence on oncogenic KIT signaling. Top-line results from registration-directed trials in Non-Advanced SM, Advanced SM and GIST are expected in 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor. In addition, the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.

Our Team https://cogent.culturehq.com

Responsibilities

Lead the strategic and tactical execution of field (commercial customer-facing) operations supporting the launch of bezuclastinib across three indications, Cogent Biosciences’ key pipeline asset.

Serve as a key member of the Commercial Operations and Analytics leadership team, responsible for driving operational excellence for the commercial organization.

Design, implement, and continuously improve the customer-facing operating model; partner with senior sales leadership to optimize field deployment, execution, and operational readiness for upcoming launches.

Bring strategic and executional perspective to enable a best-in-class launch through deep expertise in CRM systems, analytics, field operations, and cross-functional collaboration.

Field Planning and Execution Operational Leadership

Develop and lead field planning processes (national and regional) to enable launches in rare disease and oncology, including business and call planning, targeting and segmentation, resource allocation, budgeting, reporting, and sales enablement tools.

Lead the annual cadence of field engagements and meetings (business reviews, key sales meetings, performance updates, etc.).

Develop field performance management and monitoring systems, processes and reporting aligned with stakeholders’ needs.

Ensure compliance with regulatory and legal requirements, including credentialing and spend reporting.

Enabling Customer Facing Teams with Technology, Tools and Systems

Identify key technology capabilities to support a productive customer-facing organization across functions.

Collaborate with IT, L&D, and Marketing to develop, integrate and implement field-facing tools such as CRM, call/business planning tools, tablets, and virtual selling capabilities.

Oversee onboarding and ongoing training requirements for the field to adopt new technology and processes.

Develop and implement SOPs for the field to improve effectiveness.

Identify opportunities to leverage technology or digital solutions to improve productivity and engagement.

Oversee vendor relationships related to CRM, data analytics, and field operations platforms.

Performance Management, Monitoring and Reporting

Lead an aligned approach to measurable indicators and outcomes related to field performance and execution.

Develop scalable reporting capabilities, field dashboards, KPIs, and scorecards to enable actionable insights and coaching.

Collaborate with commercial leadership to establish the Sales Incentive Plan philosophy and build the SIP integration plan for the field (quota setting, data sources, reporting, payout processes, QA/QC).

Build field response processes to address data, IC, and compensation inquiries.

Launch Readiness and Deployment/Territory Optimization

Work with senior leadership and external partners to design a fit-for-purpose customer-facing organization with the right capabilities for a best-in-class launch.

Optimize deployment of field resources and geographies aligned with market opportunities across three indications; define HCP targeting and centers of excellence in each territory.

Support the scale and build of field operations resourcing and infrastructure in preparation for launch.

Represent field readiness and milestones as part of the Launch Readiness workstream for Day 1 activation.

Qualifications

Bachelor’s degree in Business, Life Sciences, or related field; MBA or advanced degree preferred.

8+ years of experience in pharmaceutical or biotech field operations, with launch experience in rare or specialty diseases.

Proven expertise in CRM systems (e.g., Veeva, Salesforce), field analytics, and commercial data infrastructure.

Strong understanding of field force effectiveness, territory design, and incentive compensation.

Experience in a startup or growth-stage biotech environment preferred.

Excellent project management, communication, and cross-functional collaboration skills.

Ability to thrive in a dynamic, fast-paced, and highly regulated environment.

Locations

Waltham, MA — Our Boston office includes an open office layout designed for collaboration with on-site parking and gym facilities.

Boulder, CO — Recently moved into a state-of-the-art Research Facility; CEO based full-time in this location.

Our Offer To You To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance-based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time-off, a 401(k) plan, and commuter/parking benefits.

We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.

#J-18808-Ljbffr